Medications starting with

Poland
  • CROHNAX

    It is used in the treatment of ulcerative colitis where the lesions are located in the rectum. It has an anti-inflammatory effect on the rectal wall.

    Dosage form: suppositories

    Active substance Dosage
    mesalazine 1000 mg

    ATC code: A07EC02

    Manufacturer: Farmina Sp. z o.o.

  • It is used in the treatment of ulcerative colitis where the lesions are located in the rectum. It acts anti-inflammatorily on the rectal wall.

    Dosage form: suppositories

    Active substance Dosage
    mesalazine 500 mg

    ATC code: A07EC02

    Manufacturer: Farmina Sp. z o.o.

  • The medicine is used in the case of seasonal or perennial allergic rhinitis.

    Dosage form: solution, nasal spray

    Active substance Dosage
    sodium cromoglicate 2.8 mg

    ATC code: R01AC01

    Manufacturer: Salutas Pharma GmbH

  • Crosuvo is used to treat high cholesterol levels in adults, adolescents, and children over 6 years of age. It helps to lower 'bad' cholesterol (LDL-C) levels and increase 'good' cholesterol (HDL-C) levels, which reduces the risk of heart attack, stroke, or other atherosclerosis-related diseases.

    Dosage form: tablets, film-coated

    Active substance Dosage
    rosuvastatin calcium 40 mg

    ATC code: C10AA07

    Manufacturer: Adamed Pharma S.A.

  • Crosuvo is used to treat high cholesterol in adults, adolescents, and children aged 6 years and older. It helps to lower 'bad' cholesterol (LDL-C) levels and increase 'good' cholesterol (HDL-C) levels, which reduces the risk of heart attack, stroke, or other health problems.

    Dosage form: tablets, film-coated

    Active substance Dosage
    rosuvastatin calcium 20 mg

    ATC code: C10AA07

    Manufacturer: Adamed Pharma S.A.

  • Crosuvo is used to treat high cholesterol levels in adults, adolescents, and children over 6 years of age. It helps to lower 'bad' cholesterol (LDL-C) and increase 'good' cholesterol (HDL-C), which reduces the risk of heart attack, stroke, or other atherosclerosis-related diseases.

    Dosage form: tablets, film-coated

    Active substance Dosage
    rosuvastatin calcium 10 mg

    ATC code: C10AA07

    Manufacturer: Adamed Pharma S.A.

  • Crosuvo is used to treat high cholesterol in adults, adolescents, and children over 6 years of age. It helps to lower 'bad' cholesterol (LDL-C) levels and increase 'good' cholesterol (HDL-C) levels, which reduces the risk of heart attack, stroke, or other health problems related to atherosclerosis.

    Dosage form: tablets, film-coated

    Active substance Dosage
    rosuvastatin calcium 5 mg

    ATC code: C10AA07

    Manufacturer: Adamed Pharma S.A.

  • The medicine is used to lower total cholesterol, 'bad' cholesterol (LDL), and triglycerides, as well as to increase 'good' cholesterol (HDL) levels. It is intended for individuals with elevated blood cholesterol levels for whom diet alone is insufficient to maintain normal results.

    Dosage form: tablets, film-coated

    Active substance Dosage
    rosuvastatin calcium 5.2 mg
    ezetimibe 10 mg

    ATC code: C10BA06

    Manufacturer: ELPEN Pharmaceutical Co. Inc.

  • The medicine is used to lower total cholesterol, 'bad' cholesterol (LDL), and triglycerides, as well as to increase 'good' cholesterol (HDL) levels. It is intended for individuals with elevated blood cholesterol levels for whom diet alone is insufficient to maintain normal results.

    Dosage form: tablets, film-coated

    Active substance Dosage
    rosuvastatin calcium 10.4 mg
    ezetimibe 10 mg

    ATC code: C10BA06

    Manufacturer: ELPEN Pharmaceutical Co. Inc.

  • The medicine is used to lower total cholesterol, 'bad' cholesterol (LDL), and triglycerides, as well as to increase 'good' cholesterol (HDL) levels. It is intended for individuals with elevated blood cholesterol levels (primary hypercholesterolemia) for whom diet alone is insufficient.

    Dosage form: tablets, film-coated

    Active substance Dosage
    rosuvastatin calcium 20.8 mg
    ezetimibe 10 mg

    ATC code: C10BA06

    Manufacturer: ELPEN Pharmaceutical Co. Inc.

  • The medicine is used to lower total cholesterol, 'bad' cholesterol (LDL), and triglycerides, as well as to increase 'good' cholesterol (HDL) levels. It is intended for individuals with elevated blood cholesterol levels for whom diet alone is insufficient to maintain normal results.

    Dosage form: tablets, film-coated

    Active substance Dosage
    rosuvastatin calcium 41.6 mg
    ezetimibe 10 mg

    ATC code: C10BA06

    Manufacturer: ELPEN Pharmaceutical Co. Inc.

  • The medicine is used to treat scabies and as an aid in relieving pruritus (itching) of various origins, including allergic pruritus and itching after insect bites.

    Dosage form: ointment

    Active substance Dosage
    crotamiton 10 g

    ATC code: P03AX

    Manufacturer: Pharmaceutical Enterprise Farmapol Ltd.

  • The medicinal product is used to treat scabies and to relieve pruritus (itching) of various origins, including allergic pruritus and pruritus following insect bites.

    Dosage form: solution, for application to the skin

    Active substance Dosage
    crotamiton 10 g

    ATC code: P03AX

    Manufacturer: Pharmaceutical Enterprise Farmapol Ltd.

  • The medicine is used to treat existing blood clots and to prevent the formation of new ones. It is used, among other things, before and after surgical procedures, during acute illness with limited mobility, in the case of clots caused by cancer, in unstable angina pectoris, after a myocardial infarction, and to prevent clots in dialyzer tubing.

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    sodium enoxaparin 40 mg/0.4 ml

    ATC code: B01AB05

    Manufacturer: Rovi Pharma Industrial Services, S.A.

  • The medicine is used to treat existing blood clots (it prevents them from growing and helps the body dissolve them) and to prevent the formation of new clots. It may be used, among other things, before and after surgery, during acute illness with limited mobility, in the case of cancer-induced clots, in unstable angina pectoris, after a myocardial infarction, and to prevent clots in dialyzer tubing.

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    sodium enoxaparin 60 mg/0.6 ml

    ATC code: B01AB05

    Manufacturer: Rovi Pharma Industrial Services, S.A.

  • The medicine is used to treat existing blood clots and to prevent the formation of new ones. It is used, among other things, before and after surgery, in the course of diseases that limit mobility, in the case of clots caused by cancer, in unstable angina pectoris, after a myocardial infarction, and to prevent clots in dialyzer tubing.

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    sodium enoxaparin 80 mg/0.8 ml

    ATC code: B01AB05

    Manufacturer: Rovi Pharma Industrial Services, S.A.

  • Crusia is used to treat existing blood clots and to prevent the formation of new ones. It is prescribed, among other things, in the case of surgical procedures, diseases that limit mobility, cancers, unstable angina pectoris, after myocardial infarction, and to prevent blood clotting in dialyzer tubing.

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    enoxaparin sodium 120 mg/0.8 ml

    ATC code: B01AB05

    Manufacturer: Rovi Pharma Industrial Services, S.A.

  • The medicine is used to treat existing blood clots and to prevent the formation of new ones. It may be used, among other things, before and after surgery, during acute illness with limited mobility, in the case of cancer-induced clots, in unstable angina pectoris, after a myocardial infarction, and to prevent blood clotting in dialyzer tubing.

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    sodium enoxaparin 150 mg/ml

    ATC code: B01AB05

    Manufacturer: Rovi Pharma Industrial Services, S.A.

  • Crusia is used to treat existing blood clots and to prevent the formation of new ones. It is also used after surgical procedures, in the course of certain diseases (e.g., cancer or unstable angina pectoris), after a myocardial infarction, and to prevent the formation of clots in dialyzer tubing.

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    sodium enoxaparin 100 mg/ml

    ATC code: B01AB05

    Manufacturer: Rovi Pharma Industrial Services, S.A.

  • The medicine is used to treat existing blood clots and to prevent the formation of new ones. It is also used to prevent clots after surgery, during certain diseases, after a myocardial infarction, in unstable angina pectoris, and in patients undergoing dialysis.

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    sodium enoxaparin 20 mg/0.2 ml

    ATC code: B01AB05

    Manufacturer: Rovi Pharma Industrial Services, S.A.

  • The medicine is used in adults for the treatment of a certain type of chronic heart failure. This occurs when the heart is too weak to pump an adequate amount of blood to the lungs and the rest of the body.

    Dosage form: tablets, film-coated

    Active substance Dosage
    sacubitril sodium 102.4 mg
    valsartan sodium salt 113.2 mg

    ATC code: C09DX04

    Manufacturer: Synthon B.V., Synthon Hispania S.L.

  • The medicine is used in adults to treat a certain type of chronic heart failure. This occurs when the heart is too weak to pump an adequate amount of blood to the lungs and the rest of the body.

    Dosage form: tablets, film-coated

    Active substance Dosage
    sacubitril sodium 51.2 mg
    valsartan sodium 56.6 mg

    ATC code: C09DX04

    Manufacturer: Synthon B.V., Synthon Hispania S.L.

  • The medicine is used in adults to treat a certain type of chronic heart failure. This occurs when the heart is too weak to pump an adequate amount of blood to the lungs and the rest of the body.

    Dosage form: tablets, film-coated

    Active substance Dosage
    sacubitril sodium 25.6 mg
    valsartan sodium salt 28.3 mg

    ATC code: C09DX04

    Manufacturer: Synthon B.V., Synthon Hispania S.L.

  • The drug is used in Wilson's disease (abnormal copper metabolism), in the treatment of rheumatoid arthritis, in the treatment and prevention of cystinuria, in the treatment of lead poisoning, and in chronic active hepatitis.

    Dosage form: tablets, film-coated

    Active substance Dosage
    penicillamine 250 mg

    ATC code: M01CC01

    Manufacturer: Teva Operations Poland Sp. z o.o.

  • The medicinal product is intended for the treatment of severe forms of acne (nodular, conglobate, or with a risk of permanent scarring) that do not respond to standard antibacterial or topical treatments.

    Dosage form: capsules, soft gelatin

    Active substance Dosage
    isotretinoin 10 mg

    ATC code: D10BA01

    Manufacturer: Pierre Fabre Medicament

  • It is used in the treatment of severe forms of acne (e.g., nodular, conglobate acne, or acne with a risk of permanent scarring) that do not respond to standard antibacterial treatment.

    Dosage form: capsules, soft gelatin

    Active substance Dosage
    isotretinoin 20 mg

    ATC code: D10BA01

    Manufacturer: Catalent France Beinheim SA, Catalent Germany Eberbach GmbH, Catalent Germany Schorndorf GmbH

  • The medicine is intended for the treatment of severe forms of acne (such as nodular, conglobate, or acne with a risk of permanent scarring) that do not respond to standard antibiotic treatment or topical medications.

    Dosage form: capsules, soft gelatin

    Active substance Dosage
    isotretinoin 40 mg

    ATC code: D10BA01

    Manufacturer: Catalent France Beinheim SA, Catalent Germany Eberbach GmbH, Catalent Germany Schorndorf GmbH

  • The medicine is intended for the treatment of severe forms of acne (nodular, conglobate, or with a risk of permanent scarring) that do not respond to standard antibiotic treatment or topical medications.

    Dosage form: capsules, soft gelatin

    Active substance Dosage
    isotretinoin 5 mg

    ATC code: D10BA01

    Manufacturer: Pierre Fabre Iberica, S.A.

  • The medicine is intended for the treatment of severe forms of acne (nodular, conglobate, or with a risk of permanent scarring) that do not respond to standard antibiotic treatment or topical medications.

    Dosage form: capsules, soft gelatin

    Active substance Dosage
    isotretinoin 5 mg

    ATC code: D10BA01

    Manufacturer: Pierre Fabre Medicament

  • It is used in the treatment of severe forms of acne (e.g., nodular, conglobate acne, or acne with a risk of permanent scarring) that do not respond to standard antibiotic treatment or topical medications.

    Dosage form: capsules, soft gelatin

    Active substance Dosage
    isotretinoin 5 mg

    ATC code: D10BA01

    Manufacturer: Pierre Fabre Iberica, S.A.

  • The medicinal product is intended for the treatment of severe forms of acne (nodular, conglobate, or with a risk of permanent scarring) that do not respond to standard antibiotic treatment or topical medications.

    Dosage form: capsules, soft gelatin

    Active substance Dosage
    isotretinoin 5 mg

    ATC code: D10BA01

    Manufacturer: Pierre Fabre Iberica, S.A.

  • The medicine is used in mild or moderate forms of plaque psoriasis.

    Dosage form: ointment

    Active substance Dosage
    tacalcitol 0,000417 g/100 g

    ATC code: D05AX04

    Manufacturer: Almirall Hermal GmbH

  • The medicine is used to treat and prevent respiratory distress syndrome (RDS) in newborns, especially premature infants, who are born with a deficiency of natural surfactant.

    Dosage form: suspension for inhalation and bronchial use

    Active substance Dosage
    poractant alfa 80 mg/ml

    ATC code: R07AA02

    Manufacturer: Chiesi Farmaceutici SpA

  • The medicine is used for the treatment and prevention of respiratory distress syndrome (RDS) in newborns, especially premature infants, who are born with a deficiency of natural surfactant.

    Dosage form: suspension for inhalation and bronchial use

    Active substance Dosage
    poractant alfa 80 mg/ml

    ATC code: R07AA02

    Manufacturer: Chiesi Farmaceutici S.p.A.

  • The medicine is used to treat eye and eyelid infections caused by bacteria sensitive to erythromycin. It may also be used to prevent certain eye infections in newborns.

    Dosage form: ointment, for eyes

    ATC code: S01AA17

    Manufacturer: NTC S.r.l.

  • The medicine is used to treat eye and eyelid infections caused by bacteria sensitive to erythromycin. It may also be used to prevent certain eye infections in newborns.

    Dosage form: ointment, for eyes

    Active substance Dosage
    erythromycin 5 mg/g

    ATC code: S01AA17

    Manufacturer: NTC s.r.l.

  • The medicine is used to treat eye and eyelid infections caused by bacteria sensitive to erythromycin. It may also be used to prevent certain eye infections in newborns.

    Dosage form: ointment, for eyes

    Active substance Dosage
    erythromycin 5 mg/g

    ATC code: S01AA17

    Manufacturer: NTC S.r.L.

  • It is used in the treatment of allergic eye diseases, such as seasonal and perennial allergic conjunctivitis, spring keratoconjunctivitis, allergic (atopic) keratitis, and allergies related to contact lens use.

    Dosage form: drops, ophthalmic

    Active substance Dosage
    sodium cromoglycate 40 mg

    ATC code: S01GX01

    Manufacturer: Novartis Farmaceutica, S.A. Novartis Pharma GmbH SIEGFRIED El Masnou, S.A.

  • The medicine is used to reduce intraocular pressure. It is indicated for the treatment of elevated intraocular pressure in ocular hypertension and chronic open-angle glaucoma.

    Dosage form: drops, ophthalmic solution

    Active substance Dosage
    timolol maleate 6.83 mg

    ATC code: S01ED01

    Manufacturer: SIEGFRIED El Masnou, S.A.

  • Cutaquig is used in adults and children to supplement antibody (immunoglobulin) deficiency. It is intended for individuals with primary immunodeficiency (born with a reduced ability to produce antibodies) and individuals with acquired immunodeficiency who experience severe or recurrent infections.

    Dosage form: solution for injection

    Active substance Dosage
    human normal immunoglobulin 165 mg/ml

    ATC code: J06BA01

    Manufacturer: Octapharma AB Octapharma GmbH Octapharma Pharmazeutika Produktionsges.m.b.H.

  • The medicine is used topically to treat inflammatory lesions and itching in skin diseases such as: atopic dermatitis (including atopic eczema and infantile eczema), nummular eczema, allergic contact dermatitis, scabies (nodular or localized), psoriasis (excluding generalized forms), lichen planus, lupus erythematosus (cutaneous form), and seborrheic dermatitis (as adjunctive treatment), as well as for severe reactions to insect bites.

    Dosage form: ointment

    Active substance Dosage
    fluticasone propionate 0.005 g

    ATC code: D07AC17

    Manufacturer: Delpharm Poznan S.A.

  • The medicine is used topically to treat inflammatory lesions and itching in skin diseases such as: atopic dermatitis (including atopic eczema and infantile eczema), nummular eczema, allergic contact dermatitis, scabies, psoriasis (excluding generalized lesions), lichen planus, lupus erythematosus (cutaneous form), seborrheic dermatitis, and large reactions following insect bites.

    Dosage form: cream

    Active substance Dosage
    fluticasone propionate 0.5 mg/g

    ATC code: D07AC17

    Manufacturer: GlaxoSmithKline (Ireland) Limited

  • The medicine is used topically for the treatment of inflammatory lesions and pruritus (itching) in skin diseases such as: atopic dermatitis (including atopic eczema and infantile eczema), nummular eczema, allergic contact eczema, scabies (nodular or localized), psoriasis (excluding generalized lesions), lichen planus, lupus erythematosus (cutaneous form), and seborrheic dermatitis (as adjunctive treatment), as well as for severe reactions to insect bites.

    Dosage form: cream

    Active substance Dosage
    fluticasone propionate 0.5 mg/g

    ATC code: D07AC17

    Manufacturer: GlaxoSmithKline (Ireland) Limited

  • The medicine is intended for patients with a weakened immune system who have an antibody deficiency and a tendency toward frequent infections. It is used for replacement therapy in individuals with congenital antibody deficiency and in patients with secondary immunodeficiency resulting from other diseases or treatments.

    Dosage form: solution for injection

    Active substance Dosage
    human normal immunoglobulin 1 g, 2 g, 4 g or 8 g

    ATC code: J06BA01

    Manufacturer: Baxalta Belgium Manufacturing S.A.

  • The medicine is used in patients after an organ, bone marrow, or stem cell transplant to prevent transplant rejection. It is also used in the treatment of autoimmune diseases, such as certain eye diseases, severe skin conditions (atopic dermatitis, psoriasis), rheumatoid arthritis, and nephrotic syndrome.

    Dosage form: capsules, soft gelatin

    Active substance Dosage
    ciclosporin 25 mg

    ATC code: L04AD01

    Manufacturer: Medis International as, production plant Bolatice Monteresearch s.r.l.

  • The medicine is used in patients after an organ, bone marrow, or stem cell transplant to prevent transplant rejection. It is also used in the treatment of autoimmune diseases, such as certain eye diseases, severe cases of atopic dermatitis, psoriasis, rheumatoid arthritis, and nephrotic syndrome.

    Dosage form: capsules, soft gelatin

    Active substance Dosage
    ciclosporin 100 mg

    ATC code: L04AD01

    Manufacturer: Medis International as, production plant Bolatice Monteresearch s.r.l.

  • The medicine is used to reduce the body's immune response. In patients following an organ, bone marrow, or stem cell transplant, it prevents transplant rejection. It is also used in the treatment of autoimmune diseases, such as certain eye diseases, severe skin conditions (atopic dermatitis, psoriasis), rheumatoid arthritis, and nephrotic syndrome.

    Dosage form: capsules, soft gelatin

    Active substance Dosage
    ciclosporin 50 mg

    ATC code: L04AD01

    Manufacturer: Medis International as, production plant Bolatice Monteresearch s.r.l.

  • The medicinal product is used for the treatment of symptoms related to venous insufficiency (such as pain and a feeling of heaviness in the legs) and as an adjunct in the case of ailments related to hemorrhoids.

    Dosage form: capsules, hard

    Active substance Dosage
    active ingredient 1 150 mg
    active substance 2 150 mg
    active substance 3 100 mg

    ATC code: C05C

    Manufacturer: Pierre Fabre Medicament

  • The medicinal product is used to treat symptoms of venous insufficiency, such as pain and a feeling of heaviness in the legs, and as an adjunct treatment for symptoms related to hemorrhoids.

    Dosage form: capsules, hard

    Active substance Dosage
    active ingredient 1 150 mg
    active substance 2 150 mg
    active substance 3 100 mg

    ATC code: C05C

    Manufacturer: Pierre Fabre Medicament

  • The medicinal product is used in adults to relieve symptoms of venous insufficiency (such as pain and a feeling of heaviness in the legs) and as an adjunct in the case of complaints related to anal varices (hemorrhoids).

    Dosage form: capsules, hard

    Active substance Dosage
    active ingredient 1 150 mg
    active substance 2 150 mg
    active substance 3 100 mg

    ATC code: C05C

    Manufacturer: Pierre Fabre Medicament